Activity of GR30921X (NSC 382057) and GR63178A (NSC D611615) in human ovarian cancer lines.
Boven
E
E
Free University Hospital, Department of Oncology, Amsterdam, The Netherlands.
Erkelens
C A
CA
Luning
M
M
Pinedo
H M
HM
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002460:Cell Line; D005260:Female; D006801:Humans; D054833:Isoindoles; D007546:Isoquinolines / Q000627:therapeutic use*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011809:Quinones / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D054833:Isoindoles; D007546:Isoquinolines; D009943:Organophosphorus Compounds; D011809:Quinones; C056077:mitoquidone; C072687:fosquidone